ADMA

ADMA Biologics is a biopharmaceutical company focused on developing, manufacturing, and commercializing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases.

Headquartered in Ramsey, New Jersey, ADMA produces FDA-approved immune globulin therapies, including ASCENIV and BIVIGAM, primarily serving patients with primary immunodeficiency disorders.

The company operates plasma collection centers and a manufacturing facility to ensure a steady supply of its products.